Brief: Hutchmed Says Tagrisso Plus Orpathys Demonstrated Clinically Meaningful Response Rate In Lung Cancer Patients

HUTCHMED (China)

16/10/2024 07:10

Oct 16 (Reuters) - HUTCHMED (China):
    * ANNOUNCES THAT TAGRISSO PLUS ORPATHYS DEMONSTRATED HIGH,
CLINICALLY MEANINGFUL RESPONSE RATE IN LUNG CANCER PATIENTS

Further company coverage:  0013.HK 

 ((Reuters.Briefs@thomsonreuters.com;))